Research Topics
Species | Linda N GengSummaryAffiliation: Fred Hutchinson Cancer Research Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Immunodetection of human double homeobox 4Linda N Geng
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Hybridoma (Larchmt) 30:125-30. 2011..Immunostaining with these new antibodies reveals a differential effect of two DUX4 isoforms on human muscle cells. These antibodies will provide an excellent tool for investigating the role of DUX4 in FSHD pathogenesis...
DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophyLinda N Geng
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Dev Cell 22:38-51. 2012..These findings suggest specific mechanisms of FSHD pathology and identify candidate biomarkers for disease diagnosis and progression...
Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed geneLauren Snider
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
PLoS Genet 6:e1001181. 2010..Therefore, FSHD represents the first human disease to be associated with the incomplete developmental silencing of a retrogene array normally expressed early in development...
RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophyLauren Snider
Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Hum Mol Genet 18:2414-30. 2009..Together, we have identified new sense and anti-sense RNA transcripts, novel mRNAs and mi/siRNA-sized RNA fragments generated from the D4Z4 units that are new candidates for the pathophysiology of FSHD...
DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differencesScott J Diede
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Proc Natl Acad Sci U S A 107:234-9. 2010..This finding warrants strong consideration for DNA demethylating agents in future clinical trials for children with this disease...
